Immutep Ltd Files Form 6-K
Ticker: PRRUF · Form: 6-K · Filed: Feb 3, 2025 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Feb 3, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, corporate-update, foreign-private-issuer
TL;DR
IMMUTEP filed a 6-K on Jan 31, 2025. Standard update.
AI Summary
Immutep Limited filed a Form 6-K on February 3, 2025, reporting information as of January 31, 2025. The company, previously known as Prima BioMed Ltd, is incorporated in Australia and operates in the pharmaceutical preparations sector. Its principal executive offices are located in Sydney, NSW.
Why It Matters
This filing provides an update on Immutep's corporate status and reporting information to the SEC, which is crucial for investors tracking the company's regulatory compliance and operational details.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not contain significant new financial or operational information that would inherently increase risk.
Key Players & Entities
- IMMUTEP Limited (company) — Registrant
- Prima BioMed Ltd (company) — Former company name
- January 31, 2025 (date) — Reporting period end date
- February 3, 2025 (date) — Filing date
- Sydney NSW (location) — Company address
FAQ
What is the primary business of IMMUTEP Limited?
IMMUTEP Limited operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code [2834].
When was IMMUTEP Limited previously known by another name?
The company was formerly known as Prima BioMed Ltd, with a date of name change on November 19, 2010.
Where is IMMUTEP Limited's principal executive office located?
Its principal executive office is located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
What form is IMMUTEP Limited filing with the SEC?
IMMUTEP Limited is filing a Form 6-K, which is a Report of Foreign Private Issuer.
What is the fiscal year end for IMMUTEP Limited?
The fiscal year end for IMMUTEP Limited is June 30 (0630).
Filing Stats: 255 words · 1 min read · ~1 pages · Grade level 17 · Accepted 2025-02-03 06:03:17
Filing Documents
- d932071d6k.htm (6-K) — 9KB
- d932071dex991.htm (EX-99.1) — 118KB
- g932071g30z01.jpg (GRAPHIC) — 7KB
- 0001193125-25-018817.txt ( ) — 139KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: January 31, 2025 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer